Onyx Pharmaceuticals, Inc. (ONXX) Posts Wider than Expected Q2 Loss of 68c/Share

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q2 EPS of ($0.68), $0.02 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $72.7 million versus the consensus estimate of $72.07 million.

For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Bernstein SocGen Group Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Market Perform
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance